Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

96.73
+0.33000.34%
Post-market: 97.500.7700+0.80%19:59 EDT
Volume:1.18M
Turnover:114.23M
Market Cap:24.30B
PE:-12.44
High:97.90
Open:96.77
Low:96.00
Close:96.40
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:1.33
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.18
PE(LYR):-17.53

Loading ...

BioNTech CEO Uğur Şahin Sells 20,500 Shares for $1.97 Million

Reuters
·
Sep 12

European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading

MT Newswires Live
·
Sep 10

Berenberg Bank Sticks to Their Hold Rating for Bilfinger (0NRG)

TIPRANKS
·
Sep 10

Opus Genetics price target raised to $16 from $13 at Chardan

TIPRANKS
·
Sep 10

BioNTech SE ADR Slides 4.9%, Underperforms Market

Dow Jones
·
Sep 09

BioNTech CEO Ugur Sahin Sells Ordinary Shares Worth $7.86 Million

Reuters
·
Sep 09

Movement Alert|BioNTech SE Falls 5.08% in Regular Trading, BMO Capital Downgrades Rating to Market Perform

Market Focus
·
Sep 08

European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

MT Newswires Live
·
Sep 08

BioNTech Se : Bmo Cuts to Market Perform from Outperform Rating

THOMSON REUTERS
·
Sep 08

BioNTech downgraded to Market Perform from Outperform at BMO Capital

TIPRANKS
·
Sep 08

Deutsche Bank AG (DB) Gets a Buy from Warburg Research

TIPRANKS
·
Sep 07

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX) and Mesoblast (MESO)

TIPRANKS
·
Sep 04

CVS Health Reports Availability of Updated COVID-19 Vaccines

MT Newswires Live
·
Sep 04

BioNTech (BNTX) Halts Cancer Trial, Is The 15% Undervaluation Still Credible?

Simply Wall St.
·
Sep 02

China's Ascletis Pharma H1 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 31

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

TIPRANKS
·
Aug 31

CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial

Reuters
·
Aug 31

BioNTech SE Slides as Bold HIV Bet Takes Shape

TIPRANKS
·
Aug 29

BioNTech SE ADR Falls 8.4%, Underperforms Market

Dow Jones
·
Aug 29

Biontech SE Stock (BNTX) Closed Down by 8.37% on Aug 28: What Signal Does It Send?

TradingKey
·
Aug 29